Literature DB >> 24453707

Meeting the needs of people with primary progressive multiple sclerosis, their families, and the health-care community.

Nancy J Holland1, Diana M Schneider1, Robert Rapp1, Rosalind C Kalb1.   

Abstract

Although major advances have been made in delaying or preventing progression for the relapsing forms of multiple sclerosis (MS), little progress has been made to date in disease management for primary progressive MS (PPMS). Treatment strategies are largely focused on managing the symptoms of the disease and providing counseling and other forms of psychosocial support. The nurse plays a major role in managing these patients. This article summarizes a collaborative effort by the National Multiple Sclerosis Society and the Multiple Sclerosis Association of America to analyze the needs of this patient population and respond with programs that will meet those needs. This approach to developing a needs assessment is broadly applicable to other patient populations.

Entities:  

Year:  2011        PMID: 24453707      PMCID: PMC3882958          DOI: 10.7224/1537-2073-13.2.65

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  29 in total

1.  Relapse, remission, and progression in multiple sclerosis.

Authors:  W I McDonald
Journal:  N Engl J Med       Date:  2000-11-16       Impact factor: 91.245

2.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

3.  Primary progressive multiple sclerosis: a comparative study of the diagnostic criteria.

Authors:  J de Seze; M Debouverie; N Waucquier; G Steinmetz; S Pittion; H Zephir; M Fleury; F Blanc; P Vermersch
Journal:  Mult Scler       Date:  2007-02-16       Impact factor: 6.312

4.  Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis.

Authors:  F D Lublin; S C Reingold
Journal:  Neurology       Date:  1996-04       Impact factor: 9.910

5.  Quality of life among persons with multiple sclerosis and their caregivers.

Authors:  K J Aronson
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

6.  A comparative study of self-efficacy in men and women with multiple sclerosis.

Authors:  Cira Fraser; Sue Polito
Journal:  J Neurosci Nurs       Date:  2007-04       Impact factor: 1.230

Review 7.  Assessment of caregiver burden in families of persons with multiple sclerosis.

Authors:  Marijean Buhse
Journal:  J Neurosci Nurs       Date:  2008-02       Impact factor: 1.230

8.  Patient-doctor interaction in rehabilitation: the relationship between perceived interaction quality and long-term treatment results.

Authors:  Susanne Dibbelt; Monika Schaidhammer; Christian Fleischer; Bernhard Greitemann
Journal:  Patient Educ Couns       Date:  2009-08-14

9.  Depression in multiple sclerosis.

Authors:  S L Minden; J Orav; P Reich
Journal:  Gen Hosp Psychiatry       Date:  1987-11       Impact factor: 3.238

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

View more
  8 in total

Review 1.  Exploring Wellness Interventions in Progressive Multiple Sclerosis: an Evidence-Based Review.

Authors:  Myriam Venasse; Thomas Edwards; Lara A Pilutti
Journal:  Curr Treat Options Neurol       Date:  2018-04-10       Impact factor: 3.598

2.  Healthcare resources utilisation in primary progressive multiple sclerosis.

Authors:  Carlo Piccinni; Giulia Ronconi; Silvia Calabria; Letizia Dondi; Emanuele Forcesi; Elisa Rossi; Antonella Pedrini; Nello Martini
Journal:  Neurol Sci       Date:  2018-04-10       Impact factor: 3.307

3.  Comparative utility of disability progression measures in PPMS: Analysis of the PROMiSe data set.

Authors:  Marcus W Koch; Gary R Cutter; Gavin Giovannoni; Bernard M J Uitdehaag; Jerry S Wolinsky; Mat D Davis; Joshua R Steinerman; Volker Knappertz
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-05-10

4.  The effect of nurse practitioner (NP-led) care on health-related quality of life in people with multiple sclerosis - a randomized trial.

Authors:  Penelope Smyth; Kaitlyn E Watson; Yazid N Al Hamarneh; Ross T Tsuyuki
Journal:  BMC Neurol       Date:  2022-07-25       Impact factor: 2.903

5.  Access to and Use of Clinical Services and Disease-Modifying Therapies by People with Progressive Multiple Sclerosis in the United Kingdom.

Authors:  Evan Campbell; Elaine H Coulter; Paul Mattison; Angus McFadyen; Linda Miller; Lorna Paul
Journal:  Int J MS Care       Date:  2017 Nov-Dec

Review 6.  Experiences of UK health-care services for people with Multiple Sclerosis: a systematic narrative review.

Authors:  Abigail M Methley; Carolyn Chew-Graham; Stephen Campbell; Sudeh Cheraghi-Sohi
Journal:  Health Expect       Date:  2014-07-02       Impact factor: 3.377

7.  Who is Taking Care of the Caregiver?

Authors:  Amy Burleson Sullivan; Deborah Miller
Journal:  J Patient Exp       Date:  2015-05-01

8.  Perspectives from the Patient and the Healthcare Professional in Multiple Sclerosis: Social Media and Patient Education.

Authors:  Daniel Kantor; Jeremy R Bright; Jeri Burtchell
Journal:  Neurol Ther       Date:  2017-12-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.